Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
5.60
+0.42 (8.11%)
Nov 21, 2024, 11:58 AM CET

Hyloris Pharmaceuticals Revenue

Hyloris Pharmaceuticals had revenue of 4.64M EUR in the half year ending June 30, 2024, with 349.18% growth. This brings the company's revenue in the last twelve months to 6.94M, up 112.46% year-over-year. In the year 2023, Hyloris Pharmaceuticals had annual revenue of 4.21M with 76.54% growth.

Revenue (ttm)
6.94M
Revenue Growth
+112.46%
P/S Ratio
21.24
Revenue / Employee
169.29K
Employees
41
Market Cap
145.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.21M1.83M76.54%
Dec 31, 20222.39M-709.00K-22.90%
Dec 31, 20213.10M2.92M1,669.14%
Dec 31, 2020175.00K84.00K92.31%
Dec 31, 201991.00K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition